CIK: 0001351351 · Show all filings
Period: Q2 2021 (← Previous) (Next →)
Filing Date: Aug 16, 2021
Total Value ($000): $264,642 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | SLACK TECHNOLOGIES INC | 1,963,061 | $86,964 | 32.9% | $42.49 | — | COM CL A | 83088V102 |
| — | ALEXION PHARMACEUTICALS INC | 353,881 | $65,011 | 24.6% | $163.79 | — | COM | 015351109 |
| — | MAXIM INTEGRATED PRODS INC | 616,245 | $64,928 | 24.5% | $105.36 | — | COM | 57772K101 |
| — | XILINX INC | 102,718 | $14,857 | 5.6% | $144.37 | — | COM | 983919101 |
| — | KANSAS CITY SOUTHERN | 44,738 | $12,677 | 4.8% | $280.37 | — | COM NEW | 485170302 |
| — | PROOFPOINT INC | 55,867 | $9,707 | 3.7% | $173.75 | — | COM | 743424103 |
| — | GRACE W R & CO DEL NEW | 55,227 | $3,817 | 1.4% | $66.39 | — | COM | 38388F108 |
| — | WELBILT INC | 87,330 | $2,022 | 0.8% | $23.15 | — | COM | 949090104 |
| — | PRA HEALTH SCIENCES INC | 11,075 | $1,830 | 0.7% | $165.24 | — | COM | 69354M108 |
| TGTX | TG THERAPEUTICS INC | 17,500 | $679 | 0.3% | $48.05 | -18.3% | COM | 88322Q108 |
| — | FOLEY TRASIMENE ACQUISTN COR | 256,560 | $534 | 0.2% | $1.60 | — | *W EXP 05/26/202 | 34431F112 |
| — | SUPERNOVA PARTNERS ACQUISITI | 50,060 | $497 | 0.2% | $10.03 | — | COM CL A | 86846V108 |
| — | ALTISOURCE ASSET MGMT CORP | 24,781 | $477 | 0.2% | $64.97 | — | COM | 02153X108 |
| ACRS | ACLARIS THERAPEUTICS INC | 12,500 | $220 | 0.1% | $22.72 | 0.0% | COM | 00461U105 |
| — | CHP MERGER CORP | 11,708 | $116 | 0.0% | $9.91 | — | COM CL A | 12558Y106 |
| — | SCION TECH GROWTH I | 10,899 | $110 | 0.0% | $10.09 | — | UNIT 12/17/2025 | G31067120 |
| — | COHN ROBBINS HOLDINGS CORP | 10,000 | $99 | 0.0% | $9.80 | — | COM CL A | G23726105 |
| — | AVANTI ACQUISITION CORP | 10,000 | $97 | 0.0% | $9.80 | — | SHS CL A | G0682V109 |